Cellectar Biosciences, Inc. Operating Loss Carryforwards
Cellectar Biosciences, Inc. (CLRB) had Operating Loss Carryforwards of $274.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2026-03-04
- 2025-12-31: Operating Loss Carryforwards $274.00K.
- 2024-12-31: Operating Loss Carryforwards $425.00K.
- 2023-12-31: Operating Loss Carryforwards $502.00K.
- 2022-12-31: Operating Loss Carryforwards $404.57K.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $274.00K 10-K · filed 2026-03-04 |
| 2024-12-31 | $425.00K 10-K · filed 2025-03-13 |
| 2023-12-31 | $502.00K 10-K/A · filed 2024-10-29 |
| 2022-12-31 | $404.57K 10-K · filed 2023-03-09 |
| 2021-12-31 | $1.30M 10-K · filed 2022-03-21 |
| 2020-12-31 | $1.69M 10-K · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |